Advisory & Consulting

Knowcraft Analytics is a prominent outsourcing service provider for global consulting firms specializing in accounting, and financial advisory services. Our seasoned professionals assist with a broad range of financial services, from M&A transactions support to capital raising. We provide transformative financial consulting solutions tailored for your success and are one-stop solution provider for the everchanging Transaction Services & Investment Banking domain.

We provide end-to-end solutions for M&A transactions, from pre-deal analyses to performing Due Diligence to review of Quality of Earnings. Our investment banking offerings include comprehensive services on sell-side and buy-side advisory, business valuations, secondary and primary research. We are your trusted partner in achieving and exceeding your financial goals, enabling you to focus on growing the clientele, while we assist you with preparing detailed operational deliverables.

Transaction Due Diligence

Read More

A thorough due diligence reduces the risks associated with M&A deals and helps one evaluate for what they are worth and what they are not. Within a short time frame, our team can assist you in preparing crucial pieces of due diligence reports including:

  • Historical Financial Analysis
  • Working Capital Analysis
  • Evaluating Appropriateness of Accounting Policies
  • Critical Agreements

Quality of Earnings

Read More
A QoE report measures how a company accumulates its revenues, including recurring or nonrecurring, and cash or non-cash. Ensure the accuracy and reliability of financial data with our QoE analysis. Our seasoned team of financial analysts assists your team in delving deep into the financial statements, providing a comprehensive assessment of the target company’s earnings and gain insights into the sustainability of these earnings and future financial performance. Knowcraft understands that each firm is unique and needs to be analyzed critically to ensure fairness of purchase price, financing terms, etc. involved in any transaction.

Investment Banking Support

Read More

At Knowcraft, we offer unparalleled investment banking and transaction advisory support services to propel your financial success. We understand the importance of assessing the strategic fit and evaluating synergies before any deal is consummated. Our team combines their years of experience with technology in performing pre-deal analyses and provides a suite of services, some of which include:

  1. Merger & Acquisition
    • Buy-Side Advisory
    • Sell-Side Advisory
    • Pitchbooks
    • Confidential Information Memorandums (CIMs)
    • Company Profiles
    • Investment Teasers
    • Financial Modeling
  2. Business Enterprise Valuation
    • Industry Research
    • Precedent Transactions
    • Trading Comparable Analysis
    • Sector Research
    • Thematic Research
    • Newsletters
  3. Presentation & Graphics Support
    • End-to-end preparation of Presentations
    • Designing Factsheets, Pitchbooks, CIMs, Teasers, Brochures, Newsletters

Experts Behind the Wheel

Why Choose Knowcraft for Advisory and Consulting?

Executed Over 100 Engagements

Scalable Investment Banking Support Services

In-depth Research

Efficient and Highly Responsive Team

Case Studies

Contingent Consideration Valuation

Contingent Consideration Valuation

THE CLIENT AND THE ASK: A pharmaceutical company (the “Acquirer”) acquired a biotechnology company (the “Company”) in exchange for an upfront payment and certain payments contingent upon successful achievement of future regulatory and sales milestones for certain...

Forecasting and Valuation

Forecasting and Valuation

THE COMPANY AND THE ASK: The Company is a technology company with a business proposition to provide diagnostic services to rural India and reduce the turnaround time of getting the report from 24 hours to 1 hour. The Company was operating using multiple business...

IRC – 409A Valuation of Common Stock

IRC – 409A Valuation of Common Stock

THE COMPANY: A biotechnology company (the “Company”) engaged in the development of an Influenza vaccine as its flagship product with others in the pipeline. The lead drug was in the pre-clinical phase of development, as of the date of valuation. The Company had raised...

Contact Us